| Scientific Name |
LECANEMAB
|
|---|---|
| Brand Name |
Leqembi
|
| Risk |
To remind healthcare professionals in Saudi Arabia of the following: • Potential risk of death associated with Amyloid-Related Imaging Abnormalities with Edema (ARIA-E) linked to Lecanemab. • To remind HCPs and patients on the approved Risk minimization measures to minimize this risks of: ( ARIA-E/vasogenic cerebral oedema , ARIA-H (cerebral microhaemorrhage and superficial siderosis ) AND ARIA intracerebral haemorrhage >1 cm in Diameter. •To inform that local product information has been update
|
| Educational Materials for Healthcare Professionals |
|
| Dear Healthcare Professional Communication (DHPC) for Healthcare Professionals |
|
| Educational Materials for Patients |
|